UPDATE - Rebel Capital 2.0 Corp. Enters Into Definitive Agreement With Alzex Biomedical Group Inc. CALGARY, Alberta, Jan. 07, 2020 (GLOBE NEWSWIRE) -- Rebel Capital 2.0 Corp. ("Rebel" or the "Corporation") (TSXV: RBZ.P) is pleased to announce that it has entered into a definitive agreement dated...

Rebel Capital 2.0 Corp. Enters Into Definitive Agreement With Alzex Biomedical Group Inc. CALGARY, Alberta, Jan. 07, 2020 (GLOBE NEWSWIRE) -- Rebel Capital 2.0 Corp. ("Rebel" or the "Corporation") (TSXV: RBZ.P) is pleased to announce that it has entered into a definitive agreement dated...

Rebel Capital 2.0 Corp. Announces Proposed Qualifying Transaction CALGARY, Alberta, Sept. 30, 2019 (GLOBE NEWSWIRE) -- Rebel Capital 2.0 Corp. ("Rebel" or the "Corporation") is pleased to announce that it has entered into a letter of intent with Alzex BioMedical...

Rebel Capital 2.0 Corp. Announces Appointment of Directors and Officers Not for distribution to U.S. Newswire Services or for dissemination in the United States of America.  Any failure to comply with this restriction may constitute a violation of U.S. Securities laws. ...

Rebel Capital 2.0 Corp. to Commence Trading on the TSX Venture Exchange After Closing of Initial Public Offering CALGARY, Alberta, Nov. 21, 2018 (GLOBE NEWSWIRE) -- Rebel Capital 2.0 Corp. ("Rebel Capital" or the "Corporation") is pleased to announce that it has successfully completed its initial public...